2000
DOI: 10.1016/s0969-8051(00)00111-6
|View full text |Cite
|
Sign up to set email alerts
|

Fluoro analogs of WAY-100635 with varying pharmacokinetics properties

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
19
0

Year Published

2001
2001
2016
2016

Publication Types

Select...
9

Relationship

4
5

Authors

Journals

citations
Cited by 35 publications
(19 citation statements)
references
References 18 publications
0
19
0
Order By: Relevance
“…[ 18 F]FPWAY was produced as described (31). There were no differences in the specific activity across groups [males: 1521.2 ± 341.4, females: 2014.8 ± 331.9 (p>0.3); MR: 1454.5 ± 206.9, PR: 2081.5 ± 419.0 (p>0.2)].…”
Section: Methodsmentioning
confidence: 99%
“…[ 18 F]FPWAY was produced as described (31). There were no differences in the specific activity across groups [males: 1521.2 ± 341.4, females: 2014.8 ± 331.9 (p>0.3); MR: 1454.5 ± 206.9, PR: 2081.5 ± 419.0 (p>0.2)].…”
Section: Methodsmentioning
confidence: 99%
“…18 F]Mefway can be radiolabeled as two different isomeric forms at the 4-cyclohexyl position, representing cis-[ 18 F]mefway and trans-[ 18 F]mefway, which are shown in Figure 1. The varying binding affinity of isomeric forms of another closely related PET radioligand, 4-[ 18 F]FCWAY, has been investigated [5]. The conformation of trans- and cis- [ 18 F]FCWAY displayed a dramatic difference in 5-HT 1A binding with reported IC 50 values of 1.7nM and 21nM, respectively.…”
Section: Introductionmentioning
confidence: 99%
“…The pharmaceutical industry integrated LC/MS into its drug discovery process several years ago [8]. Identification of metabolites of radiopharmaceuticals, which is complicated by the short half-lives of the radionuclides and the very low dose of the compound [typically less than 10 nmol] administered, may provide suggestions as to the most appropriate position in the molecule to attach the radiolabel and allow the synthesis and study of the bio-distribution of the metabolite(s) [9, 10]. …”
Section: Metabolite Identificationmentioning
confidence: 99%
“…Placing the fluorine in the cyclohexane ring resulted in formation of different isomers. We examined the relationship between structure and metabolism [9, 10, 37, 38]. The first four compounds, prepared both chemically and radiochemically, were 4- cis , 4- trans , 3- cis , and 3- trans isomers of N -{2-[4-(2-metho-xyphenyl)piperazinyl]ethyl}- N -(pyridin-2-yl) -fluorocyclohexane-carboxamides (FCWAY’s) Fig.…”
Section: Metabolite Identificationmentioning
confidence: 99%